Tests an eye implant during cataract surgery in people with glaucoma
Tests an eye implant placed during cataract surgery in adults with glaucoma.
Plain-language title generated from the registry record
Registry title: Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Key facts
- Where
- Kenosha, United StatesSee the site
- Phase
- Phase 4
Where in United States
- KenoshaKenosha, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT06848946
- Record updated
- 21 January 2026
- Original description
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery aloneRead full original descriptionShow less
Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Inclusion: Cataract diagnosis: clinically significant age-related cataract eligible for phacoemulsification in the study eye; OAG or OHT diagnosis: either OAG (i.e. primary, pseudoexfoliation, or pigmentary glaucoma) or OHT in the study eye (i.e., eye to undergo cataract surgery).
Exclusion: Retinal disorders not associated with glaucoma; Active corneal inflammation or edema.